Exposure of individuals to halothane causes, in 20% of patients, a mil
d form of hepatotoxicity. In contrast, a very small subset of individu
als only develops halothane hepatitis, which is thought to have an imm
unological basis. Sera of halothane hepatitis patients contain antibod
ies directed against some discrete liver trifluoroacetyl (TFA)-protein
adducts, which arise upon oxidative biotransformation of halothane an
d include protein disulfide isomerase, microsomal carboxylesterase, ca
lreticulin, ERp72, GRP 78 and ERp99. No immune response occurs in the
majority of human individuals, although evidence suggests that TFA-pro
tein adducts arise in all halothane-exposed individuals. The lack of i
mmunological responsiveness of individuals might be due to tolerance,
induced by a presumed repertoire of self-peptides that molecularly mim
ic TFA-protein adducts. Thus, constitutively expressed proteins of 52
and 64 kDa have been identified that confer molecular mimicry of TFA-p
rotein adducts. The 64 kDa protein corresponds to the E2 subunit of th
e mitochondrial pyruvate dehydrogenase complex. Lipoic acid, the prost
hetic group of the E2 subunit, is involved in the molecular mimicry pr
ocess. A fraction of halothane hepatitis patients exhibit irregulariti
es in the expression levels of the 52 kDa protein and the E2 subunit p
rotein. Molecular mimicry of TFA-protein adducts by the 52 kDa protein
and the E2 subunit protein might play a role in the susceptibility of
individuals to development of halothane hepatitis.